Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Booth

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Frontiers in Cellular and Infection Microbiology|July 3, 2018
Development of a High-Throughput <i>ex-Vivo</i> Burn Wound Model Using Porcine Skin, and Its Application to Evaluate New Approaches to Control Wound InfectionDiana R Alves, Simon P Booth, Paola Scavone, et al.
Molecular Vision|July 29, 2010
Homozygous FOXE3 mutations cause non-syndromic, bilateral, total sclerocornea, aphakia, microphthalmia and optic disc colobomaManir Ali, Beatriz Buentello-Volante, Martin McKibbin, et al.
American Heart Journal|April 21, 2009
Assessing proarrhythmic potential of drugs when optimal studies are infeasibleEdwin P Rock, John Finkle, Howard J Fingert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Pemetrexed in malignant pleural mesotheliomaMaitreyee Hazarika, Robert M White, Brian P Booth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinomaVicki L Goodman, Edwin P Rock, Ramzi Dagher, et al.
Clinical Pharmacology and Therapeutics|December 31, 2010
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory reviewP Zhao, L Zhang, J A Grillo, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 3, 2017
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall responseHongshan Li, Jingyu Yu, Chao Liu, et al.
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
Bioanalysis|November 30, 2010
2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidanceNatasha Savoie, Fabio Garofolo, Peter van Amsterdam, et al.
American Journal of Human Genetics|May 5, 2009
Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in miceDavid A Parry, Carmel Toomes, Lina Bida, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Frontiers in Cellular and Infection Microbiology|July 3, 2018
Development of a High-Throughput <i>ex-Vivo</i> Burn Wound Model Using Porcine Skin, and Its Application to Evaluate New Approaches to Control Wound InfectionDiana R Alves, Simon P Booth, Paola Scavone, et al.
Molecular Vision|July 29, 2010
Homozygous FOXE3 mutations cause non-syndromic, bilateral, total sclerocornea, aphakia, microphthalmia and optic disc colobomaManir Ali, Beatriz Buentello-Volante, Martin McKibbin, et al.
American Heart Journal|April 21, 2009
Assessing proarrhythmic potential of drugs when optimal studies are infeasibleEdwin P Rock, John Finkle, Howard J Fingert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Pemetrexed in malignant pleural mesotheliomaMaitreyee Hazarika, Robert M White, Brian P Booth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinomaVicki L Goodman, Edwin P Rock, Ramzi Dagher, et al.
Clinical Pharmacology and Therapeutics|December 31, 2010
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory reviewP Zhao, L Zhang, J A Grillo, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 3, 2017
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall responseHongshan Li, Jingyu Yu, Chao Liu, et al.
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
Bioanalysis|November 30, 2010
2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidanceNatasha Savoie, Fabio Garofolo, Peter van Amsterdam, et al.
American Journal of Human Genetics|May 5, 2009
Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in miceDavid A Parry, Carmel Toomes, Lina Bida, et al.
Pageof 15